Objectives We sought to quantitatively determine the interobserver variability of expert radiotherapy target-volume delineation for thymic cancers, as part of a larger effort to develop an expert-consensus contouring atlas. Methods A pilot dataset was created consisting of a standardized case presentation with pre-and post-operative DICOM CT image sets from a single patient with Masaoka-Koga Stage III thymoma. Expert thoracic radiation oncologists delineated tumor targets on the pre-and post-operative scans as they would for a definitive and adjuvant case, respectively.
Introduction
Radiation therapy (RT) is recommended in the postoperative treatment of thymoma and thymic carcinoma in Presented, in part, at the 14th World Conference on Lung Cancer, July 3-7, 2011, Amsterdam, The Netherlands. the cases of microscopic or macroscopic positive margins and can be considered for patients with more advanced disease who have had a complete resection [1] . RT is also given for patients who are inoperable either for tumorrelated or medical comorbidity reasons [2, 3] . The studies initially describing RT for thymic malignancies were performed in the 1980s and 1990s and utilized cobalt-60 units to deliver radiation to the entire mediastinum and the lung and pleura adjacent to the resected tumor via an anterior and posterior field arrangement until cord tolerance was reached, then angled off-cord oblique fields were commonly used [4] . Reported grade 3 to 5 toxicities from therapy in this era ranged from 10 to 15 % [4] and included tracheoarterial fistula [5] , pericarditis [6] , pneumonitis [7] , cardiac conduction abnormalities [8] , and esophageal stricture [9] .
The advent of conformal, image-guided RT allows for the delivery of tumoricidal radiation doses to physiciandelineated target volumes while minimizing dose to nearby organs-at-risk and potentially reduces significant pulmonary toxicity rates down to 5-10 % [10] . Intensity modulated RT (IMRT) further allows for an improved therapeutic ratio through the use of Binverse planning^to optimize dose to the tumor while preferentially sparing organs at risk [11] . However, target volumes and organs-at-risk for treatment planning are necessarily defined by human users, introducing possible geometric variability due to variation in target delineation [12] . Under-contouring can lead to local relapse, and over-contouring can lead to unnecessary normal tissue toxicity. Accurate target delineation by the treating physician is not only the most critical step of the process but also the most susceptible to error [13] . Several groups have sought to account for systematic variability introduced in target delineation in order to optimize volume definition and treatment planning margins [14] [15] [16] . The location of the target volume appears to influence the frequency and magnitude of contouring error. Fritton et al. reported 8 mm interobserver variability with CT-based planning for mediastinal nonsmall-cell lung cancer (NSCLC) [17] .
Thymic neoplasms present a unique set of challenges in terms of target delineation for conformal radiotherapy. The rarity of thymic tumors means that heterogenous radiotherapy approaches are often reported in retrospective series. An expert-consensus atlas would not only be invaluable as a resource for physicians who infrequently treat thymic tumors but could also serve a validated benchmark for future clinical trials using conformal radiotherapy. Through this project, we sought to quantitatively determine the relative interobserver variability of expert target volume delineation, which we hypothesized would be similar to that noted in NSCLC contouring atlases: mean Dice similarity coefficient (DSC) between 0.6 and 0.8 [17] .
Methods

Case selection
IRB approval for anonymized data utilization for this study has been approved as Bexempt^under University of Texas Health Science Center IRB # HSC200B0166E. A pilot dataset was created consisting of a standardized case presentation with anonymized pre-and post-operative DICOM CT image sets from a single patient with Masaoka-Koga Stage III thymoma. Datasets consisted of a treatment planning CT, and fused MRI and FDG-PET. Each case session consisted of specific axial slices through derived from the DICOM file of an actual patient without any HiPPA-defined patient-specific information. This was performed by anonymizing the patient DICOM data using DCMAnonymize DICOM Validation Toolkit (DVTk.org). Associated diagnostic imaging was also available for reference.
Data collection
The anonymized DICOM file was made available along with a PDF containing an anonymized clinical vignette. Participating thoracic radiation oncologists contoured, using a treatment planning system of their choice, the gross tumor volume (GTV), and clinical target volumes (CTV) as they would in their standard practice, in both a definitive (pre-op scan) and adjuvant (post-op) setting. After submission of contours as DICOM RTSTRUCT files for central analysis, users completed a survey detailing the dose prescription and PTV margins they would recommend in definitive and post-operative (i.e., R1 vs R2) scenarios. Data submission and analysis were semiautomated using BTarget Contour Testing/Instructional Computer Software^(TaCTICS; http://skynet.ohsu.edu/tactics/), a target delineation statistical software with a graphical user interface (GUI), developed at Oregon Health and Science University [18, 19] . TaCTICS allows for near real-time data analysis and reporting of quantitative scoring metrics that compare user-derived structures with reference sets derived from other expert users. Additionally, TaCTICS serves as a cost-effective central repository of contouring data for planned central analysis.
Data analysis
Interobserver variability was analyzed quantitatively with Warfield's simultaneous truth and performance level estimation (STAPLE) algorithm to generate a composite segmentation estimate of a Bground truth^target volume, which was then compared to each individual experts contours as a DSC [where DSC=1 indicates total agreement, while DSC=0 indicates no overlapping TV voxels] using nonparametric analysis [20] [21] [22] .
Results
A total of seven expert thoracic radiation oncologists who are members of the International Thymic Malignancy Interest Group (ITMIG) completed the contouring tasks for definitive and post-operative cases; of these, five completed online surveys. Details are listed in Table 1 .
Hausdorff distances were calculated for the GTV, pre-op CTV, and post-op CTVand are shown in Fig. 1a . The Hausdorff distance measures how far two subsets are from each other and is defined as the greatest of all the distances from a point in one set to the closest point in the other set. Segmentation performance was assessed, with high mean±SD STAPLE-estimated segmentation sensitivity for definitive case GTV and CTV at 0.77 and 0.80, respectively, and post-operative CTV sensitivity of 0.55; all volumes had specificity of ≥0.99 (Fig. 1b) .
Interobserver agreement was markedly higher for the definitive case target volumes, with mean±SD DSC of 0.88±0.03 and 0.89±0.04 for GTV and CTV, respectively, compared to post-op CTV DSC of 0.69±0.06 (Kruskal-Wallis p<0.01; Fig. 1c ) for all experts versus the STAPLE composite(s). Figure 2 shows a representative screenshot of two expert-segmented target volumes simultaneously displayed on a single axial CT slice.
Survey results indicated 60 % of experts would routinely add margins of 0.5 cm to CTV volumes for PTV generation, with 40 % advocating 1 cm expansions. All respondents suggested IMRT should be used, 80 % suggested 4DCT should be utilized for simulation, and 40 % suggested PETCT fusion should be implemented, if available, for contour delineation. For definitive cases, a PTV prescription of 50-54 Gy was suggested. Post-operatively, for R1 resections, a PTV prescription of 60-66 Gy was suggested, with 60-70 Gy for an R2 resection.
Discussion
This prospective, pilot study sought to quantify interobserver variability between expert-delineated GTV and CTV volumes for a standardized case of stage III thymoma in both the preoperative and post-operative setting. There was excellent agreement for pre-operative GTV (DSC of 0.88±0.03) and CTV (DSC of 0.89 ± 0.04), but the agreement for postoperative CTV was significantly lower (DSC of 0.69±0.06). The majority of experts surveyed stated that they would use 0.5 cm PTV margins, and all stated they would use IMRT. Recommended doses mirrored those published in international guidelines.
Currently, radiation oncologists gain skill and expertise in target and organ-at-risk delineation, also known as contouring, through clinical practice during their residency training. Differences in case volume and diversity as well as clinical teaching and supervision lead to an unavoidably heterogeneous skill-set in residency graduates. More recently, the development of educational tools and activities to assist clinicians in developing standardized target delineation skill-sets has been an active area of research.
Contouring atlases are an efficient way for experts in the field to communicate guidelines for delineating both target volumes and organs at risk to large numbers of trainees and practicing clinicians. These have been developed and published for several common cancers such as lung [23, 24] , prostate [25, 26] , breast [27] , rectum [28] , pancreas [29] , anus [30] , cervical and endometrial cancer [31, 32] , and head and neck cancer [33] . These atlases are typically assembled via consensus after target volumes and organs at risk are delineated by several established specialists for standardized test cases. Although some atlases were developed through Staging as per the Masaoka-Koga staging system. Sensitivity and specificity values for each expert contour Warfield's simultaneous truth and performance level estimation (STAPLE) algorithm to generate a composite segmentation estimate of a Bground truth^target volume, which was then compared to each individual experts contours GTV gross tumor volume, CTV clinical target volume discussion and verbal consensus among experts, DSC is often used to quantify level of agreement, as was performed in our study. The DSCs in our study ranged from 0.69±0.06 for the post-operative CTV volume to 0.89 ± 0.04 for the preoperative CTV volume and 0.88±0.03 for the pre-operative GTV volume. This compares favorably to other published target volume delineation projects. For groups publishing consensus prostate cancer target volumes, post-operative CTV Fig. 1 a Hausdorff distances were calculated for the definitive case GTV (pre-GTV), pre-CTV= definitive case CTV (pre-CTV), and post-operative CTV (post-CTV). The Hausdorff distance measures how far two subsets are from each other and is defined as the greatest of all the distances from a point in one set to the closest point in the other set. b Segmentation performance was assessed, with high mean±SD STAPLE-estimated segmentation sensitivity for pre-GTV and pre-CTV, respectively, and lower sensitivity for post-CTV. c Dice similarity coefficients distribution of all expert participants, as compared to STAPLE-estimated ground truth, where DSC=1 indicates total volumetric agreement volumes also had lower agreement between expert contours with a mean specificity of 0.5±0.25 to 0.62±0.22 [26] . For groups publishing breast cancer target volumes, mean DSCs ranged from 0.56 to 0.95 in one study [27] with the most variability in the nodal target volumes and the least variability in the tumor bed [34] .
There has been recent interest in quantifying the effects of contouring atlases on target volumes delineated in clinical practice. Studies have been recently published that demonstrate substantial improvement in target volume delineation through the use of such consensus atlases in gastrointestinal, breast, and head and neck tumor sites [35] [36] [37] ; however, limited improvement was reported after a similar education intervention in lung tumor volume delineation [38] . It can be argued that expert-consensus atlases may be even more valuable for rare tumors with which many radiation oncologists are less familiar. There is no current atlas for thymic malignancies, although recent guidelines for simulation, target volume definition and dose-volume constraints have recently been published [39] .
Further, consistent target volumes have yet to be established across series; for instance, some series report routine supraclavicular nodal coverage [40] , while others do not [41] . Thoracic anatomy is complex, and pre-operative evaluation of primary tumor extension is often more subtle than in other anatomic regions. The high interobserver agreement seen when delineating pre-operative GTV in this study suggests, at least in the hands of experts in the fields, the intact primary tumor volume can be reliably and reproducibly delineated. In practice, surgical clips are often used to help guide CTV target delineation in the post-operative setting, but number and location of clip placement often vary, and discussion of post-operative imaging with the surgeon can also help to define the area at risk.
Diagnostic radiologists often use multimodality imaging for enhanced clinical evaluation. In the setting of NSCLC, it has been suggested that reviewing PET imaging with a radiologist led to significant changes to GTV volumes for stage IA-IIIB patients [42] . However, optimal multimodality techniques for tumor definition such as 18FDG-PET [43, 44] and MRI [45, 46 ] have yet to be determined for thymic malignancies. Additionally, physiologic motion of the thorax provides an impediment to accurate imaging due to motion artifact on PET, CT, and MRI imaging, and introduces uncertainty during therapy due to intrafraction and interfraction motion of the tumor and surrounding normal tissues. Additionally, while 4DCT for motion correction is recognized as useful for thoracic tumors generally, implementation remains unstandardized with regard to how to optimally implement motion-correction for target volume delineation/treatment of mediastinal tumors. In our survey, 80 % of expert respondents suggested implementation of 4DCT for simulation, and 40 % suggested implementation of PETCT. These suggestions, as well as the ranges of doses and PTV margin, are in line with a recently published consensus statement [39] .
The initial results of this pilot study are encouraging, and the applications of these data are many. First, further case studies will be released for expert contouring in order to create an online atlas. In addition to use in clinical practice, our hope is that this atlas can also serve as a tool to help standardize radiation therapy planning for future multi-institutional clinical trials. Many ongoing and recently closed trials have provided participating institutions and physicians with contouring atlases for assistance with consistent and accurate target delineation. Furthermore, prior pilot studies in rectal cancer have demonstrated that consensus guideline atlas implementation improves interobserver agreement and a greater approximation of expert target volumes in the cooperative group setting [36, 47] .
Obviously, our use of a single case for this analysis presents a significant limitation on the generalizability of this dataset. Nonetheless, this effort represents, to our knowledge, the first prospectively collected quantitative assessment of target volume delineation for thymic malignancies and is a landmark effort for ITMIG. Our data suggest that experts can, with little oversight, achieve statistically comparable target volumes for gross tumor and pre-therapy clinical target volumes, but that agreement post-operatively is much lower. This suggests that, either a consensus atlas intervention as demonstrated in rectal [36] or head and neck [37] could be used to standardize volumes for prospective radiotherapy trials. Alternatively, contouring of pre-surgical volumes (which exhibit high agreement) with subsequent registration to post-therapy scans could be utilized, provided sufficient quality assurance of the registration method is performed [48, 49] .
Conclusions
Expert agreement for definitive case GTV and CTV volumes was exceptionally high, though significantly lower agreement was noted for post-operative CTV. Technique and dose prescription between experts was substantively consistent. Data from this preliminary analysis will be used to generate educational materials to assist non-expert target delineation through guideline and atlas implementation. Future efforts will seek to assess the impact of 4DCT and PET imaging on target delineation variability. 
